{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T10:31:16Z","timestamp":1793442676183,"version":"4.5.0"},"reference-count":189,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,9,25]],"date-time":"2027-09-25T00:00:00Z","timestamp":1821830400000},"content-version":"am","delay-in-days":328,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008656","name":"Iketani Science and Technology Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008656","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["25K01831"],"award-info":[{"award-number":["25K01831"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jconrel.2026.115395","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:37:00Z","timestamp":1790177820000},"page":"115395","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"PB","title":["Amino acid-based zwitterionic interfaces for transporter-mediated drug delivery"],"prefix":"10.1016","volume":"399","author":[{"given":"Jokichi","family":"Fukushima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shota","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoki","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2026.115395_bb0005","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.addr.2020.06.005","article-title":"Exploiting the dynamics of the EPR effect and strategies to improve the therapeutic effects of nanomedicines by using EPR effect enhancers","volume":"157","author":"Fang","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.115395_bb0010","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jconrel.2022.03.043","article-title":"Strategies to improve the EPR effect: a mechanistic perspective and clinical translation","volume":"345","author":"Ikeda-Imafuku","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115395_bb0015","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.addr.2018.07.007","article-title":"Tumor targeting via EPR: strategies to enhance patient responses","volume":"130","author":"Golombek","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.115395_bb0020","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41563-019-0566-2","article-title":"The entry of nanoparticles into solid tumours","volume":"19","author":"Sindhwani","year":"2020","journal-title":"Nat. Mater."},{"key":"10.1016\/j.jconrel.2026.115395_bb0025","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/s44222-024-00203-3","article-title":"Nanoparticle delivery to tumours: from EPR and ATR mechanisms to clinical impact","volume":"2","author":"Dasgupta","year":"2024","journal-title":"Nat. Rev. Bioeng."},{"key":"10.1016\/j.jconrel.2026.115395_bb0030","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1615","article-title":"Impact of the protein corona on nanomaterial immune response and targeting ability","volume":"12","author":"Digiacomo","year":"2020","journal-title":"WIREs Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2026.115395_bb0035","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1039\/c3cc37307j","article-title":"Protein corona significantly reduces active targeting yield","volume":"49","author":"Mirshafiee","year":"2013","journal-title":"Chem. Commun."},{"key":"10.1016\/j.jconrel.2026.115395_bb0040","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nnano.2012.237","article-title":"Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface","volume":"8","author":"Salvati","year":"2013","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.115395_bb0045","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ijpharm.2018.10.011","article-title":"The impact of protein corona on the behavior and targeting capability of nanoparticle-based delivery system","volume":"552","author":"Xiao","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.115395_bb0050","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1111\/cas.15006","article-title":"Amino acid transporters as emerging therapeutic targets in cancer","volume":"112","author":"Saito","year":"2021","journal-title":"Cancer Sci."},{"key":"10.1016\/j.jconrel.2026.115395_bb0055","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s13046-023-02784-0","article-title":"An amino acid transporter subunit as an antibody-drug conjugate target in colorectal cancer","volume":"42","author":"Montero","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2026.115395_bb0060","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.1038\/s41467-024-47948-4","article-title":"The complete assembly of human LAT1-4F2hc complex provides insights into its regulation, function and localisation","volume":"15","author":"Wu","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115395_bb0065","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/s41594-019-0237-7","article-title":"Cryo-EM structure of the human L-type amino acid transporter 1 in complex with glycoprotein CD98hc","volume":"26","author":"Lee","year":"2019","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.jconrel.2026.115395_bb0070","doi-asserted-by":"crossref","first-page":"17073","DOI":"10.1021\/acs.chemrev.2c00344","article-title":"Zwitterionic biomaterials","volume":"122","author":"Li","year":"2022","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2026.115395_bb0075","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1021\/bm701301s","article-title":"Zwitterionic polymers exhibiting high resistance to nonspecific protein adsorption from human serum and plasma","volume":"9","author":"Ladd","year":"2008","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2026.115395_bb0080","doi-asserted-by":"crossref","first-page":"6794","DOI":"10.1021\/la200227b","article-title":"Zwitteration as an alternative to PEGylation","volume":"27","author":"Estephan","year":"2011","journal-title":"Langmuir"},{"key":"10.1016\/j.jconrel.2026.115395_bb0085","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1093\/hmg\/ddaa186","article-title":"The amino acid transporter Slc7a5 regulates the mTOR pathway and is required for granule cell development","volume":"29","author":"Sokolov","year":"2020","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jconrel.2026.115395_bb0090","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.3390\/ijms17101636","article-title":"Recent advances in understanding amino acid sensing mechanisms that regulate mTORC1","author":"Zheng","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2026.115395_bb0095","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s00428-007-0457-9","article-title":"Expression of LAT1 predicts risk of progression of transitional cell carcinoma of the upper urinary tract","volume":"451","author":"Nakanishi","year":"2007","journal-title":"Virchows Arch."},{"key":"10.1016\/j.jconrel.2026.115395_bb0100","doi-asserted-by":"crossref","first-page":"23629","DOI":"10.1074\/jbc.273.37.23629","article-title":"Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98)*","volume":"273","author":"Kanai","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2026.115395_bb0105","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.3390\/ijms20102428","article-title":"The L-type amino acid transporter LAT1\u2014An emerging target in cancer","author":"H\u00e4fliger","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2026.115395_bb0110","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.3390\/ijms19051278","article-title":"Insights into the structure, function, and ligand discovery of the large neutral amino acid transporter 1, LAT1","author":"Singh","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2026.115395_bb0115","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0005-2736(01)00384-4","article-title":"Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines","volume":"1514","author":"Yanagida","year":"2001","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.jconrel.2026.115395_bb0120","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41586-019-1011-z","article-title":"Structure of the human LAT1-4F2hc heteromeric amino acid transporter complex","volume":"568","author":"Yan","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.115395_bb0125","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41421-021-00247-4","article-title":"Mechanism of substrate transport and inhibition of the human LAT1-4F2hc amino acid transporter","volume":"7","author":"Yan","year":"2021","journal-title":"Cell Discov."},{"key":"10.1016\/j.jconrel.2026.115395_bb0130","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s13139-010-0068-2","article-title":"Potential biomarker of L-type amino acid transporter 1 in breast cancer progression","volume":"45","author":"Liang","year":"2011","journal-title":"Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.jconrel.2026.115395_bb0135","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41586-021-03768-w","article-title":"SAR1B senses leucine levels to regulate mTORC1 signalling","volume":"596","author":"Chen","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.115395_bb0140","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jphs.2017.01.006","article-title":"Structure-activity relationship of a novel series of inhibitors for cancer type transporter L-type amino acid transporter 1 (LAT1)","volume":"133","author":"Kongpracha","year":"2017","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.jconrel.2026.115395_bb0145","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.bbagen.2017.01.013","article-title":"Novel insights into the transport mechanism of the human amino acid transporter LAT1 (SLC7A5). Probing critical residues for substrate translocation","volume":"1861","author":"Napolitano","year":"2017","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.jconrel.2026.115395_bb0150","doi-asserted-by":"crossref","first-page":"9171","DOI":"10.3390\/ijms24119171","article-title":"Genetic ablation of LAT1 inhibits growth of liver cancer cells and downregulates mTORC1 signaling","author":"Kim","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2026.115395_bb0155","first-page":"27","article-title":"Discovery of potent inhibitors for the large neutral amino acid transporter 1 (LAT1) by structure-based methods","author":"Singh","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2026.115395_bb0160","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1349-7006.2009.01386.x","article-title":"L-type amino acid transporter 1 inhibitors inhibit tumor cell growth","volume":"101","author":"Oda","year":"2010","journal-title":"Cancer Sci."},{"key":"10.1016\/j.jconrel.2026.115395_bb0165","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s13046-018-0907-z","article-title":"The LAT1 inhibitor JPH203 reduces growth of thyroid carcinoma in a fully immunocompetent mouse model","volume":"37","author":"H\u00e4fliger","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2026.115395_bb0170","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1093\/jnci\/djt241","article-title":"Targeting amino acid transport in metastatic castration-resistant prostate cancer: effects on cell cycle, cell growth, and tumor development","volume":"105","author":"Wang","year":"2013","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"10.1016\/j.jconrel.2026.115395_bb0175","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.3390\/cells9092028","article-title":"Membrane transporters for amino acids as players of cancer metabolic rewiring","author":"Scalise","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.jconrel.2026.115395_bb0180","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2018.00096","article-title":"The human SLC1A5 (ASCT2) amino acid transporter: from function to structure and role in cell biology","volume":"6","author":"Scalise","year":"2018","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.jconrel.2026.115395_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114552","article-title":"ASCT2 is a major contributor to serine uptake in cancer cells","volume":"43","author":"Conger","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.jconrel.2026.115395_bb0190","doi-asserted-by":"crossref","first-page":"474","DOI":"10.3390\/receptors3040024","article-title":"The regulation and function of the amino acid transporters LAT1, ASCT2, xCT in urological cancers","author":"Zhao","year":"2024","journal-title":"Receptors"},{"key":"10.1016\/j.jconrel.2026.115395_bb0195","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1038\/bjc.2014.88","article-title":"ASC amino-acid transporter 2 (ASCT2) as a novel prognostic marker in non-small cell lung cancer","volume":"110","author":"Shimizu","year":"2014","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jconrel.2026.115395_bb0200","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1021\/acs.jmedchem.3c01093","article-title":"Discovery of novel Aminobutanoic acid-based ASCT2 inhibitors for the treatment of non-small-cell lung cancer","volume":"67","author":"Qin","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jconrel.2026.115395_bb0205","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1476-5381.2011.01480.x","article-title":"System xc- cystine\/glutamate antiporter: an update on molecular pharmacology and roles within the CNS","volume":"165","author":"Bridges","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jconrel.2026.115395_bb0210","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00726-011-0867-5","article-title":"The oxidative stress-inducible cystine\/glutamate antiporter, system xc\u2212: cystine supplier and beyond","volume":"42","author":"Conrad","year":"2012","journal-title":"Amino Acids"},{"key":"10.1016\/j.jconrel.2026.115395_bb0215","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s10637-021-01070-0","article-title":"System Xc\u2212: a key regulatory target of ferroptosis in cancer","volume":"39","author":"Liu","year":"2021","journal-title":"Investig. New Drugs"},{"key":"10.1016\/j.jconrel.2026.115395_bb0220","doi-asserted-by":"crossref","DOI":"10.31083\/j.fbl2803057","article-title":"Glial glutamate transporter-mediated plasticity: system xc-\/xCT\/SLC7A11 and EAAT1\/2 in brain diseases","volume":"28","author":"Dahlmanns","year":"2023","journal-title":"Front. Biosci. (Landmark Ed)"},{"key":"10.1016\/j.jconrel.2026.115395_bb0225","article-title":"System Xc\u2212\/GSH\/GPX4 axis: an important antioxidant system for the ferroptosis in drug-resistant solid tumor therapy","volume":"13","author":"Li","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2026.115395_bb0230","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2026.115395_bb0235","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1021\/acsnano.8b05602","article-title":"Nanolongan with multiple on-demand conversions for Ferroptosis-apoptosis combined anticancer therapy","volume":"13","author":"Bao","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115395_bb0240","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202203973","article-title":"Targeted xCT-mediated ferroptosis and protumoral polarization of macrophages is effective against HCC and enhances the efficacy of the anti-PD-1\/L1 response","volume":"10","author":"Tang","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2026.115395_bb0245","doi-asserted-by":"crossref","first-page":"13194","DOI":"10.1074\/jbc.M115.700534","article-title":"Deletion of amino acid transporter ASCT2 (SLC1A5) reveals an essential role for transporters SNAT1 (SLC38A1) and SNAT2 (SLC38A2) to sustain glutaminolysis in cancer cells*","volume":"291","author":"Br\u00f6er","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2026.115395_bb0250","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0005-2736(00)00390-4","article-title":"Evidence for the transport of neutral as well as cationic amino acids by ATA3, a novel and liver-specific subtype of amino acid transport system A","volume":"1510","author":"Hatanaka","year":"2001","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.jconrel.2026.115395_bb0255","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.neuroscience.2004.09.023","article-title":"Immunohistochemical localization of the amino acid transporter SNAT2 in the rat brain","volume":"130","author":"Gonz\u00e1lez-Gonz\u00e1lez","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.jconrel.2026.115395_bb0260","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/s41416-020-01113-y","article-title":"Increased expression of glutamine transporter SNAT2\/SLC38A2 promotes glutamine dependence and oxidative stress resistance, and is associated with worse prognosis in triple-negative breast cancer","volume":"124","author":"Morotti","year":"2021","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jconrel.2026.115395_bb0265","first-page":"1289","article-title":"SNAT2 transceptor signalling via mTOR: a role in cell growth and proliferation?","volume":"3","author":"Pinilla","year":"2011","journal-title":"Front. Biosci. (Elite Ed.)"},{"key":"10.1016\/j.jconrel.2026.115395_bb0270","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.963066","article-title":"Identification and characterization of a novel SNAT2 (SLC38A2) inhibitor reveals synergy with glucose transport inhibition in cancer cells","volume":"13","author":"Gauthier-Coles","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2026.115395_bb0275","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.594464","article-title":"Amino acid transporter SLC6A14 (ATB0,+) \u2013 a target in combined anti-cancer therapy","volume":"8","author":"Na\u0142\u0119cz","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.jconrel.2026.115395_bb0280","doi-asserted-by":"crossref","first-page":"23740","DOI":"10.1074\/jbc.274.34.23740","article-title":"Cloning and functional expression of a human Na+and Cl\u2212\u2212dependent neutral and cationic amino acid transporter B0+*","volume":"274","author":"Sloan","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2026.115395_bb0285","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1124\/jpet.103.057109","article-title":"Transport of amino acid-based prodrugs by the Na+\u2212 and Cl--coupled amino acid transporter ATB0,+ and expression of the transporter in tissues amenable for drug delivery","volume":"308","author":"Hatanaka","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2026.115395_bb0290","doi-asserted-by":"crossref","first-page":"31830","DOI":"10.1074\/jbc.M111.229518","article-title":"SLC6A14 (ATB0,+) protein, a highly concentrative and broad specific amino acid transporter, is a novel and effective drug target for treatment of estrogen receptor-positive breast cancer*","volume":"286","author":"Karunakaran","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2026.115395_bb0295","first-page":"15","article-title":"Resetting amino acid metabolism of cancer cells by ATB0,+-targeted nanoparticles for enhanced anticancer therapy","volume":"9","author":"Kou","year":"2022","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.jconrel.2026.115395_bb0300","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jconrel.2016.10.031","article-title":"Transporter occluded-state conformation-induced endocytosis: amino acid transporter ATB0,+-mediated tumor targeting of liposomes for docetaxel delivery for hepatocarcinoma therapy","volume":"243","author":"Luo","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115395_bb0305","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1039\/C6BM00788K","article-title":"ATB0,+ transporter-mediated targeting delivery to human lung cancer cells via aspartate-modified docetaxel-loading stealth liposomes","volume":"5","author":"Luo","year":"2017","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2026.115395_bb0310","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jconrel.2019.10.037","article-title":"Tyrosine modified irinotecan-loaded liposomes capable of simultaneously targeting LAT1 and ATB0,+ for efficient tumor therapy","volume":"316","author":"Wang","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115395_bb0315","doi-asserted-by":"crossref","first-page":"G1046","DOI":"10.1152\/ajpgi.00233.2007","article-title":"Transport of butyryl-L-carnitine, a potential prodrug, via the carnitine transporter OCTN2 and the amino acid transporter ATB(0,+)","volume":"293","author":"Srinivas","year":"2007","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.jconrel.2026.115395_bb0320","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1080\/10717544.2017.1377316","article-title":"Dual targeting of l-carnitine-conjugated nanoparticles to OCTN2 and ATB0,+ to deliver chemotherapeutic agents for colon cancer therapy","volume":"24","author":"Kou","year":"2017","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2026.115395_bb0325","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201700165","article-title":"Cotransporting ion is a trigger for cellular endocytosis of transporter-targeting nanoparticles: a case study of high-efficiency SLC22A5 (OCTN2)-mediated carnitine-conjugated nanoparticles for Oral delivery of therapeutic drugs","volume":"6","author":"Kou","year":"2017","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2026.115395_bb0330","doi-asserted-by":"crossref","first-page":"4091","DOI":"10.3390\/cancers15164091","article-title":"Optimizing boron neutron capture therapy (BNCT) to treat cancer: an updated review on the latest developments on boron compounds and strategies","author":"Monti Hughes","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.jconrel.2026.115395_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122605","article-title":"BNCT pancreatic cancer treatment strategy with glucose-conjugated boron drug","volume":"309","author":"Fujimoto","year":"2024","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2026.115395_bb0340","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202402893","article-title":"Boronophenylalanine-containing polydopamine nanoparticles for enhanced combined boron neutron capture therapy and photothermal therapy for melanoma treatment","volume":"34","author":"Dai","year":"2024","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2026.115395_bb0345","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jconrel.2023.06.026","article-title":"Levodopa-loaded nanoparticles for the treatment of Parkinson\u2019s disease","volume":"360","author":"van Vliet","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115395_bb0350","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1080\/10837450.2020.1740257","article-title":"In vitro and in vivo evaluation of levodopa-loaded nanoparticles for nose to brain delivery","volume":"25","author":"Arisoy","year":"2020","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.jconrel.2026.115395_bb0355","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.2174\/1570159X15666170510143821","article-title":"Levodopa in Parkinson\u2019s disease: current status and future developments","volume":"16","author":"Nicola","year":"2018","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.jconrel.2026.115395_bb0360","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/mds.26082","article-title":"Levodopa therapy for Parkinson\u2019s disease: pharmacokinetics and pharmacodynamics","volume":"30","author":"LeWitt","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jconrel.2026.115395_bb0365","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3390\/ph15030370","article-title":"Design and development of levodopa loaded polymeric nanoparticles for intranasal delivery","author":"Ahmad","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.jconrel.2026.115395_bb0370","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/ejn.14119","article-title":"L-DOPA for Parkinson\u2019s disease \u2014 a bittersweet pill","volume":"49","author":"Lane","year":"2019","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.jconrel.2026.115395_bb0375","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1021\/cn5001759","article-title":"Classics in chemical neuroscience: levodopa","volume":"5","author":"Whitfield","year":"2014","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.jconrel.2026.115395_bb0380","article-title":"Melphalan delivery and co-delivery nanoformulations for cancer therapy: a comprehensive review","volume":"12","author":"Abdouss","year":"2024","journal-title":"Europ. J. Med. Chem. Rep."},{"key":"10.1016\/j.jconrel.2026.115395_bb0385","doi-asserted-by":"crossref","first-page":"4479","DOI":"10.1038\/s41598-020-61436-x","article-title":"Chemical modification of melphalan as a key to improving treatment of haematological malignancies","volume":"10","author":"Gajek","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2026.115395_bb0390","article-title":"A real-world data study of the effect of co-solvent differences on the clinical safety of melphalan for injection","volume":"12","author":"Wang","year":"2025","journal-title":"Front. Med."},{"key":"10.1016\/j.jconrel.2026.115395_bb0395","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0021-9258(17)34167-4","article-title":"Active carrier-mediated transport of melphalan by two separate amino acid transport systems in LPC-1 plasmacytoma cells in vitro","volume":"254","author":"Goldenberg","year":"1979","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2026.115395_bb0400","first-page":"1571","article-title":"Facilitated transport of Melphalan at the rat blood-brain barrier by the large neutral amino acid carrier system","volume":"47","author":"Greig","year":"1987","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2026.115395_bb0405","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jconrel.2022.05.063","article-title":"Strategies for persistent retention of macromolecules and nanoparticles in the blood circulation","volume":"350","author":"Takakura","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115395_bb0410","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s44222-024-00154-9","article-title":"The mechanisms of nanoparticle delivery to solid tumours","volume":"2","author":"Nguyen","year":"2024","journal-title":"Nat. Rev. Bioeng."},{"key":"10.1016\/j.jconrel.2026.115395_bb0415","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s11095-008-9697-x","article-title":"Intravascular delivery of particulate systems: does geometry really matter?","volume":"26","author":"Decuzzi","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2026.115395_bb0420","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1002\/anie.201509183","article-title":"Polymeric nanoparticles amenable to simultaneous installation of exterior targeting and interior therapeutic proteins","volume":"55","author":"Zhu","year":"2016","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2026.115395_bb0425","doi-asserted-by":"crossref","first-page":"23125","DOI":"10.1021\/acs.langmuir.4c02664","article-title":"Zwitterionic polymers for biomedical applications: antimicrobial and antifouling strategies toward implantable medical devices and drug delivery","volume":"40","author":"Moayedi","year":"2024","journal-title":"Langmuir"},{"key":"10.1016\/j.jconrel.2026.115395_bb0430","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/s41565-023-01381-8","article-title":"Tailoring renal-clearable zwitterionic cyclodextrin for colorectal cancer-selective drug delivery","volume":"18","author":"Baek","year":"2023","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.115395_bb0435","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.115395_bb0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.114079","article-title":"To PEGylate or not to PEGylate: immunological properties of nanomedicine\u2019s most popular component, polyethylene glycol and its alternatives","volume":"180","author":"Shi","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.115395_bb0445","doi-asserted-by":"crossref","first-page":"26269","DOI":"10.1038\/srep26269","article-title":"Surface modification of nanoparticles enables selective evasion of phagocytic clearance by distinct macrophage phenotypes","volume":"6","author":"Qie","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2026.115395_bb0450","article-title":"Enhanced immunocompatibility and hemocompatibility of nanomedicines across multiple species using complement pathway inhibitors","volume":"11","author":"Li","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2026.115395_bb0455","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2165\/00003495-199700544-00007","article-title":"Safety aspects of Pegylated liposomal doxorubicin in patients with cancer","volume":"54","author":"Alberts","year":"1997","journal-title":"Drugs"},{"key":"10.1016\/j.jconrel.2026.115395_bb0460","doi-asserted-by":"crossref","first-page":"9404","DOI":"10.1021\/ja503400r","article-title":"Zwitterionic poly(amino acid methacrylate) brushes","volume":"136","author":"Alswieleh","year":"2014","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2026.115395_bb0465","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1021\/acs.biomac.2c00216","article-title":"Impact of Zwitterionic polymers on the tumor permeability of molecular bottlebrush-based nanoparticles","volume":"23","author":"Fujii","year":"2022","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2026.115395_bb0470","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1295\/polymj.22.355","article-title":"Preparation of phospholipid polymers and their properties as polymer hydrogel membranes","volume":"22","author":"Ishihara","year":"1990","journal-title":"Polym. J."},{"key":"10.1016\/j.jconrel.2026.115395_bb0475","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jconrel.2023.10.019","article-title":"Super-small zwitterionic micelles enable the improvement of blood-brain barrier crossing for efficient orthotopic glioblastoma combinational therapy","volume":"364","author":"Wang","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115395_bb0480","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202406763","article-title":"Engineered Zwitterionic Diblock copolymer-siRNA polyplexes provide highly effective treatment of triple-negative breast cancer in a 4T1 murine model","volume":"34","author":"Jeon","year":"2024","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2026.115395_bb0485","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1038\/s41551-021-00701-4","article-title":"Enhanced tumour penetration and prolonged circulation in blood of polyzwitterion-drug conjugates with cell-membrane affinity","volume":"5","author":"Chen","year":"2021","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2026.115395_bb0490","doi-asserted-by":"crossref","first-page":"11625","DOI":"10.1021\/la302433a","article-title":"Superhydrophilic Zwitterionic polymers stabilize liposomes","volume":"28","author":"Cao","year":"2012","journal-title":"Langmuir"},{"key":"10.1016\/j.jconrel.2026.115395_bb0495","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/s41551-018-0234-x","article-title":"Micelles with ultralow critical micelle concentration as carriers for drug delivery","volume":"2","author":"Lu","year":"2018","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2026.115395_bb0500","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1021\/acs.biomac.3c00247","article-title":"Carboxybetaine-based Zwitterionic polymer nanogels with Long blood circulation for cancer therapy","volume":"24","author":"Mai","year":"2023","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2026.115395_bb0505","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s40005-024-00703-9","article-title":"Zwitterionic alginate derivative as a new delivery platform for enhanced blood circulation","volume":"55","author":"Lee","year":"2025","journal-title":"J. Pharm. Investig."},{"key":"10.1016\/j.jconrel.2026.115395_bb0510","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0378-5173(02)00075-3","article-title":"Effects of mixed polyethyleneglycol modification on fixed aqueous layer thickness and antitumor activity of doxorubicin containing liposome","volume":"238","author":"Sadzuka","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.115395_bb0515","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/S0006-3495(98)77849-X","article-title":"Hydration of polyethylene glycol-grafted liposomes","volume":"74","author":"Tirosh","year":"1998","journal-title":"Biophys. J."},{"key":"10.1016\/j.jconrel.2026.115395_bb0520","doi-asserted-by":"crossref","first-page":"5283","DOI":"10.1016\/j.polymer.2010.08.022","article-title":"Surface hydration: principles and applications toward low-fouling\/nonfouling biomaterials","volume":"51","author":"Chen","year":"2010","journal-title":"Polymer"},{"key":"10.1016\/j.jconrel.2026.115395_bb0525","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jconrel.2011.09.093","article-title":"Uptake mechanisms of non-viral gene delivery","volume":"158","author":"Xiang","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115395_bb0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.copbio.2023.103046","article-title":"Impact of protein coronas on nanoparticle interactions with tissues and targeted delivery","volume":"85","author":"Chou","year":"2024","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115395_bb0535","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202101536","article-title":"PLGA\u2019S plight and the role of stealth surface modification strategies in its use for intravenous particulate drug delivery","volume":"11","author":"Sheffey","year":"2022","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2026.115395_bb0540","series-title":"Biomaterials Science (Fourth Edition)","first-page":"507","article-title":"Nonfouling surfaces","author":"Zhang","year":"2020"},{"key":"10.1016\/j.jconrel.2026.115395_bb0545","doi-asserted-by":"crossref","first-page":"14473","DOI":"10.1021\/ja054169u","article-title":"Strong resistance of Phosphorylcholine self-assembled monolayers to protein adsorption: insights into nonfouling properties of Zwitterionic materials","volume":"127","author":"Chen","year":"2005","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2026.115395_bb0550","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1038\/nbt1340","article-title":"Renal clearance of quantum dots","volume":"25","author":"Soo Choi","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115395_bb0555","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114895","article-title":"Stealth and pseudo-stealth nanocarriers","volume":"198","author":"Wen","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.115395_bb0560","first-page":"1445","article-title":"Steric stabilization-independent stealth cloak enables nanoreactors-mediated starvation therapy against refractory cancer, nature","volume":"10","author":"Li","year":"2026","journal-title":"Biomed. Eng."},{"key":"10.1016\/j.jconrel.2026.115395_bb0565","doi-asserted-by":"crossref","first-page":"6083","DOI":"10.1039\/D1PY01010G","article-title":"Internalization into cancer cells of zwitterionic amino acid polymers via amino acid transporter recognition","volume":"12","author":"Takano","year":"2021","journal-title":"Polym. Chem."},{"key":"10.1016\/j.jconrel.2026.115395_bb0570","doi-asserted-by":"crossref","first-page":"3968","DOI":"10.1021\/acs.biomac.2c00803","article-title":"Zwitterionic amino acid polymer-grafted core-crosslinked particle toward tumor delivery","volume":"23","author":"Fujii","year":"2022","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2026.115395_bb0575","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202600064","article-title":"Engineering cylindrical macromolecular assemblies with zwitterionic amino acids for concurrent prolonged circulation and tumor targeting","volume":"22","author":"Fukushima","year":"2026","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2026.115395_bb0580","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1039\/D2BM01541B","article-title":"Histidine-based coordinative polymers for efficient intracellular protein delivery via enhanced protein binding, cellular uptake, and endosomal escape","volume":"11","author":"Chen","year":"2023","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2026.115395_bb0585","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202303857","article-title":"Modulating lipid nanoparticles with Histidinamide-conjugated cholesterol for improved intracellular delivery of mRNA","volume":"13","author":"Jung","year":"2024","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2026.115395_bb0590","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1021\/acs.biomac.6b00172","article-title":"Membrane translocation and organelle-selective delivery steered by polymeric Zwitterionic nanospheres","volume":"17","author":"Morimoto","year":"2016","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2026.115395_bb0595","article-title":"Zwitterionic internalizable peptide-drug conjugates: tumor-selective ultrafast uptake and transcytosis for enhanced antitumor therapy","volume":"21","author":"Zhao","year":"2025","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2026.115395_bb0600","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1523-1755.2004.00722.x","article-title":"Over-expression of renal LAT1 and LAT2 and enhanced L-DOPA uptake in SHR immortalized renal proximal tubular cells","volume":"66","author":"Pinho","year":"2004","journal-title":"Kidney Int."},{"key":"10.1016\/j.jconrel.2026.115395_bb0605","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.1021\/acs.molpharmaceut.2c00328","article-title":"L-type amino acid transporter 1 utilizing Ferulic acid derivatives show increased drug delivery in the mouse pancreas along with decreased lipid peroxidation and prostaglandin production","volume":"19","author":"Tampio","year":"2022","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2026.115395_bb0610","doi-asserted-by":"crossref","first-page":"6443","DOI":"10.1021\/acsomega.9b00216","article-title":"LAT1-targeting thermoresponsive liposomes for effective cellular uptake by cancer cells","volume":"4","author":"Maekawa-Matsuura","year":"2019","journal-title":"ACS Omega"},{"key":"10.1016\/j.jconrel.2026.115395_bb0615","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119680","article-title":"Single-ligand dual-targeting irinotecan liposomes: control of targeting ligand display by pH-responsive PEG-shedding strategy to enhance tumor-specific therapy and attenuate toxicity","volume":"587","author":"Wang","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.115395_bb0620","doi-asserted-by":"crossref","first-page":"30031","DOI":"10.1021\/acsami.0c03564","article-title":"Tumor microenvironment-responsive, multistaged liposome induces apoptosis and ferroptosis by amplifying oxidative stress for enhanced cancer therapy","volume":"12","author":"Kou","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2026.115395_bb0625","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121987","article-title":"Polymeric ligands comprising sulfur-containing amino acids for targeting tumor-associated amino acid transporters","volume":"293","author":"Guo","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2026.115395_bb0630","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202003757","article-title":"Potent-by-design: amino acids mimicking porous nanotherapeutics with intrinsic anticancer targeting properties","volume":"16","author":"Wu","year":"2020","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2026.115395_bb0635","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/cas.12672","article-title":"Aspartate-modified doxorubicin on its N-terminal increases drug accumulation in LAT1-overexpressing tumors","volume":"106","author":"Wu","year":"2015","journal-title":"Cancer Sci."},{"key":"10.1016\/j.jconrel.2026.115395_bb0640","doi-asserted-by":"crossref","first-page":"7402","DOI":"10.1021\/acsabm.1c00771","article-title":"Systemically applicable glutamine-functionalized polymer exerting multivalent interaction with tumors overexpressing ASCT2","volume":"4","author":"Honda","year":"2021","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.jconrel.2026.115395_bb0645","doi-asserted-by":"crossref","first-page":"6077","DOI":"10.1038\/s41598-017-06438-y","article-title":"Engineering tumour cell-binding synthetic polymers with sensing dense transporters associated with aberrant glutamine metabolism","volume":"7","author":"Yamada","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2026.115395_bb0650","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abc2148","article-title":"A supramolecular platform for controlling and optimizing molecular architectures of siRNA targeted delivery vehicles","volume":"6","author":"Wen","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2026.115395_bb0655","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1021\/acs.bioconjchem.8b00804","article-title":"Multivalency in drug delivery \u2013 When is it too much of a good thing?","volume":"30","author":"Tjandra","year":"2019","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2026.115395_bb0660","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1021\/bm500921q","article-title":"Multivalent polymers for drug delivery and imaging: the challenges of conjugation","volume":"15","author":"van Dongen","year":"2014","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2026.115395_bb0665","doi-asserted-by":"crossref","first-page":"5887","DOI":"10.1021\/acsnano.0c01034","article-title":"Tuning the brightness and photostability of organic dots for multivalent targeted cancer imaging and surgery","volume":"14","author":"Cong","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115395_bb0670","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1007\/s13346-021-01103-4","article-title":"Critical parameters for design and development of multivalent nanoconstructs: recent trends","volume":"12","author":"Bakshi","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jconrel.2026.115395_bb0675","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1021\/ja411138s","article-title":"Superselective targeting using multivalent polymers","volume":"136","author":"Dubacheva","year":"2014","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2026.115395_bb0680","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1021\/bm5014469","article-title":"Recent advances in engineering polyvalent biological interactions","volume":"16","author":"Varner","year":"2015","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2026.115395_bb0685","doi-asserted-by":"crossref","first-page":"5579","DOI":"10.1073\/pnas.1500622112","article-title":"Designing multivalent probes for tunable superselective targeting","volume":"112","author":"Dubacheva","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2026.115395_bb0690","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1007\/s00726-014-1808-x","article-title":"Transport mechanism and regulatory properties of the human amino acid transporter ASCT2 (SLC1A5)","volume":"46","author":"Scalise","year":"2014","journal-title":"Amino Acids"},{"key":"10.1016\/j.jconrel.2026.115395_bb0695","first-page":"194","article-title":"Effect of ligand density, receptor density, and nanoparticle size on cell targeting, nanomedicine: nanotechnology","volume":"9","author":"Elias","year":"2013","journal-title":"Biol. Med."},{"key":"10.1016\/j.jconrel.2026.115395_bb0700","doi-asserted-by":"crossref","first-page":"6371","DOI":"10.1021\/acs.nanolett.5b01362","article-title":"Targeted PRINT hydrogels: the role of nanoparticle size and ligand density on cell association, biodistribution, and tumor accumulation","volume":"15","author":"Reuter","year":"2015","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2026.115395_bb0705","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jconrel.2015.04.035","article-title":"The effect of ligand density on in vivo tumor targeting of nanographene oxide","volume":"209","author":"Lee","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115395_bb0710","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1021\/acsami.8b18843","article-title":"Ligand density and linker length are critical factors for multivalent nanoparticle-receptor interactions","volume":"11","author":"Abstiens","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2026.115395_bb0715","first-page":"987","article-title":"Targeting tumor highly-expressed LAT1 transporter with amino acid-modified nanoparticles: toward a novel active targeting strategy in breast cancer therapy, nanomedicine: nanotechnology","volume":"13","author":"Li","year":"2017","journal-title":"Biol. Med."},{"key":"10.1016\/j.jconrel.2026.115395_bb0720","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.colsurfb.2016.01.041","article-title":"Large amino acid transporter 1 mediated glutamate modified docetaxel-loaded liposomes for glioma targeting","volume":"141","author":"Li","year":"2016","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2026.115395_bb0725","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102340","article-title":"L-type amino acid transporter 1-targeting nanoparticles for antisense oligonucleotide delivery to the CNS","volume":"35","author":"Lim","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.jconrel.2026.115395_bb0730","doi-asserted-by":"crossref","first-page":"6480","DOI":"10.1039\/C8SC01680A","article-title":"Exploring a new ligand binding site of G protein-coupled receptors","volume":"9","author":"Chan","year":"2018","journal-title":"Chem. Sci."},{"key":"10.1016\/j.jconrel.2026.115395_bb0735","first-page":"210","article-title":"The structural basis of peptide binding at class A G protein-coupled receptors","author":"Vu","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.jconrel.2026.115395_bb0740","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.tips.2011.09.003","article-title":"Diversity and modularity of G protein-coupled receptor structures","volume":"33","author":"Katritch","year":"2012","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jconrel.2026.115395_bb0745","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adq0558","article-title":"Structural basis for the substrate recognition and transport mechanism of the human y+LAT1-4F2hc transporter complex","volume":"11","author":"Dai","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2026.115395_bb0750","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1021\/acs.biomac.4c01591","article-title":"Effect of spacers on the affinity of tyrosine-modified polymers to L-type amino acid transporter 1","volume":"26","author":"Voon","year":"2025","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2026.115395_bb0755","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejps.2018.07.042","article-title":"Niosomes decorated with dual ligands targeting brain endothelial transporters increase cargo penetration across the blood-brain barrier","volume":"123","author":"M\u00e9sz\u00e1ros","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2026.115395_bb0760","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12987-025-00623-2","article-title":"Alanine and glutathione targeting of dopamine- or ibuprofen-coupled polypeptide nanocarriers increases both crossing and protective effects on a blood-brain barrier model","volume":"22","author":"M\u00e9sz\u00e1ros","year":"2025","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.jconrel.2026.115395_bb0765","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1469-7793.2001.0297f.x","article-title":"Rapid report","volume":"532","author":"Nakanishi","year":"2001","journal-title":"J. Physiol."},{"key":"10.1016\/j.jconrel.2026.115395_bb0770","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.bbamem.2015.11.013","article-title":"Functional activity of L-carnitine transporters in human airway epithelial cells","volume":"1858","author":"Ingoglia","year":"2016","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.jconrel.2026.115395_bb0775","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127728","article-title":"ATB0,+-targeted delivery of triptolide prodrugs for safer and more effective pancreatic cancer therapy","volume":"33","author":"Lou","year":"2021","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jconrel.2026.115395_bb0780","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.3390\/ijms21062132","article-title":"Tyrosine-Chlorambucil conjugates facilitate cellular uptake through L-type amino acid transporter 1 (LAT1) in human breast cancer cell line MCF-7","author":"Pocasap","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2026.115395_bb0785","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1021\/jm701175d","article-title":"Large neutral amino acid transporter enables brain drug delivery via prodrugs","volume":"51","author":"Gynther","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jconrel.2026.115395_bb0790","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202110560","article-title":"Endocytosis-independent and cancer-selective cytosolic protein delivery via reversible tagging with LAT1 substrate","volume":"34","author":"Zhao","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.115395_bb0795","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/3528148","article-title":"Astrocyte-targeted transporter-utilizing derivatives of Ferulic acid can have multifunctional effects ameliorating inflammation and oxidative stress in the brain","volume":"2019","author":"Montaser","year":"2019","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.jconrel.2026.115395_bb0800","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1021\/mp2001878","article-title":"Large amino acid transporter 1 (LAT1) prodrugs of Valproic acid: new prodrug design ideas for central nervous system delivery","volume":"8","author":"Peura","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2026.115395_bb0805","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1021\/acschemneuro.0c00564","article-title":"L-type amino acid transporter 1 enables the efficient brain delivery of small-sized prodrug across the blood-brain barrier and into human and mouse brain parenchymal cells","volume":"11","author":"Montaser","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.jconrel.2026.115395_bb0810","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ejps.2019.01.002","article-title":"L-type amino acid transporter 1 utilizing prodrugs of ferulic acid revealed structural features supporting the design of prodrugs for brain delivery","volume":"129","author":"Puris","year":"2019","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2026.115395_bb0815","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1021\/acs.molpharmaceut.2c00594","article-title":"Structural features affecting the interactions and transportability of LAT1-targeted phenylalanine drug conjugates","volume":"20","author":"Bahrami","year":"2023","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2026.115395_bb0820","doi-asserted-by":"crossref","DOI":"10.1016\/j.cclet.2024.110190","article-title":"The synthesis and evaluation of novel BPA derivatives for enhanced blood-brain barrier penetration and boron neutron capture therapy","volume":"36","author":"Mo","year":"2025","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.jconrel.2026.115395_bb0825","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jconrel.2021.02.021","article-title":"Fructose-functionalized polymers to enhance therapeutic potential of p-boronophenylalanine for neutron capture therapy","volume":"332","author":"Nomoto","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115395_bb0830","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jconrel.2024.11.017","article-title":"Poly(vinyl alcohol) potentiating an inert d-amino acid-based drug for boron neutron capture therapy","volume":"377","author":"Konarita","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115395_bb0835","article-title":"Boronophenylalanine-functionalized platinum nanozymes sensitizing neutron capture therapy","volume":"35","author":"Li","year":"2025","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2026.115395_bb0840","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1600-0749.1989.tb00203.x","article-title":"Complex formation of p-Boronophenylalanine with some monosaccharides","volume":"2","author":"Mori","year":"1989","journal-title":"Pigment Cell Res."},{"key":"10.1016\/j.jconrel.2026.115395_bb0845","doi-asserted-by":"crossref","first-page":"39259","DOI":"10.1021\/acsami.7b14851","article-title":"Multibranched gold nanoparticles with intrinsic LAT-1 targeting capabilities for selective photothermal therapy of breast cancer","volume":"9","author":"Ong","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2026.115395_bb0850","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.jddst.2019.05.043","article-title":"Large amino acid transporter 1 mediated glutamate modified mesoporous silica nanoparticles for chemophotothermal therapy","volume":"52","author":"Wang","year":"2019","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.jconrel.2026.115395_bb0855","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.xphs.2020.11.008","article-title":"99mTc-methionine gold nanoparticles as a promising biomaterial for enhanced tumor imaging","volume":"110","author":"Gupta","year":"2021","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2026.115395_bb0860","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/s41467-017-00952-3","article-title":"Glycaemic control boosts glucosylated nanocarrier crossing the BBB into the brain","volume":"8","author":"Anraku","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115395_bb0865","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1021\/acschemneuro.0c00076","article-title":"GLUT-1: an effective target to deliver brain-derived neurotrophic factor gene across the blood-brain barrier","volume":"11","author":"Arora","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.jconrel.2026.115395_bb0870","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1021\/acsnano.3c09715","article-title":"Mannose-integrated nanoparticle hitchhike glucose transporter 1 recycling to overcome various barriers of oral delivery for Alzheimer\u2019s disease therapy","volume":"18","author":"Lei","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115395_bb0875","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1021\/acschemneuro.4c00392","article-title":"Mannose-functionalized chitosan-coated PLGA nanoparticles for brain-targeted codelivery of CBD and BDNF for the treatment of Alzheimer\u2019s disease","volume":"15","author":"Mahanta","year":"2024","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.jconrel.2026.115395_bb0880","first-page":"161","article-title":"Sugar ligand-mediated drug delivery, future","volume":"12","author":"Chen","year":"2020","journal-title":"Med. Chem."},{"key":"10.1016\/j.jconrel.2026.115395_bb0885","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.605037","article-title":"Glycosylated nanoparticles for cancer-targeted drug delivery","volume":"10","author":"Torres-P\u00e9rez","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jconrel.2026.115395_bb0890","doi-asserted-by":"crossref","first-page":"913","DOI":"10.3390\/pharmaceutics15030913","article-title":"A small sugar molecule with huge potential in targeted cancer therapy","author":"Pastuch-Gawo\u0142ek","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.115395_bb0895","doi-asserted-by":"crossref","first-page":"5633","DOI":"10.1002\/smll.201601249","article-title":"Amino acid metabolism abnormity and microenvironment variation mediated targeting and controlled glioma chemotherapy","volume":"12","author":"An","year":"2016","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2026.115395_bb0900","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1007\/s11051-013-2022-6","article-title":"Phenylalanine-coupled solid lipid nanoparticles for brain tumor targeting","volume":"15","author":"Kharya","year":"2013","journal-title":"J. Nanopart. Res."},{"key":"10.1016\/j.jconrel.2026.115395_bb0905","doi-asserted-by":"crossref","first-page":"9743","DOI":"10.1007\/s12274-023-5568-3","article-title":"LAT1 targeted brain delivery of temozolomide and sorafenib for effective glioma therapy","volume":"16","author":"Zhang","year":"2023","journal-title":"Nano Res."},{"key":"10.1016\/j.jconrel.2026.115395_bb0910","first-page":"1","article-title":"L-DOPA functionalized, multi-branched gold nanoparticles as brain-targeted nano-vehicles, nanomedicine: nanotechnology","volume":"15","author":"Gonzalez-Carter","year":"2019","journal-title":"Biol. Med."},{"key":"10.1016\/j.jconrel.2026.115395_bb0915","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3390\/pharmaceutics12070635","article-title":"Combination of alanine and glutathione as targeting ligands of nanoparticles enhances cargo delivery into the cells of the neurovascular unit","author":"Porkol\u00e1b","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.115395_bb0920","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3390\/cells12030503","article-title":"Targeting human endothelial cells with glutathione and alanine increases the crossing of a polypeptide nanocarrier through a blood-brain barrier model and entry to human brain organoids","author":"M\u00e9sz\u00e1ros","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.jconrel.2026.115395_bb0925","doi-asserted-by":"crossref","DOI":"10.1002\/cnma.202300324","article-title":"Glu-derived Zwitterionic micelles conquering the intestinal mucosal barrier toward oral delivery","volume":"9","author":"Liu","year":"2023","journal-title":"ChemNanoMat"},{"key":"10.1016\/j.jconrel.2026.115395_bb0930","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00592-015-0714-3","article-title":"L-valine appended PLGA nanoparticles for oral insulin delivery","volume":"52","author":"Jain","year":"2015","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.jconrel.2026.115395_bb0935","first-page":"524","article-title":"Impact of the polymer backbone chemistry on interactions of amino-acid-derived zwitterionic polymers with cells","volume":"24","author":"Leiske","year":"2023","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.jconrel.2026.115395_bb0940","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/j.cclet.2021.08.113","article-title":"A \u201ccluster bomb\u201d oral drug delivery system to sequentially overcome the multiple absorption barriers","volume":"33","author":"Song","year":"2022","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.jconrel.2026.115395_bb0945","doi-asserted-by":"crossref","first-page":"7997","DOI":"10.2147\/IJN.S183796","article-title":"Apically targeted oral micelles exhibit highly efficient intestinal uptake and oral absorption","volume":"13","author":"Jinling","year":"2018","journal-title":"Int. J. Nanomedicine"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926007996?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926007996?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T09:43:21Z","timestamp":1793439801000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926007996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":189,"alternative-id":["S0168365926007996"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115395","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amino acid-based zwitterionic interfaces for transporter-mediated drug delivery","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115395","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115395"}}